CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 18 enrolled
Drug / intervention
SmokefreeSGMbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05029362
NCT05029362N/ACompleted
CompareCT.gov

SmokefreeSGM, A Text-based Smoking Cessation Intervention for Sexual and Gender Minority Groups

The University of Texas Health Science Center, Houston·interventional·Posted Aug 31, 2021·Updated Jul 20, 2025

In Brief

A clinical study evaluating SmokefreeSGM for Smoking Cessation. Completed, enrolled 18 participants across 1 site.

Detailed Summary

The purpose of this study is to pretest the design of a text-based smoking cessation program tailored to sexual minority individuals.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSmoking Cessation
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

N/ACompletedFinished
20222023202420252026
First PostedAug 31, 2021
Enrollment StartJan 5, 2022
Primary CompletionOct 5, 2022
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 4.8 years ago

Interventions

SmokefreeSGMbehavioral

Participants will have access to a text-based smoking cessation program tailored to sexual minority individuals (SmokefreeSGM). The text-based program will be beta-tested by these participants for a period of 2 weeks before and 10 weeks after their quit date. Messages originated from the text-based smoking cessation program will be sent by a fictitious quit coach who will offer evidence-based advice on quitting smoking based on real-life experiences of sexual minority individuals.